AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

V-Glyme-M 80 Tablet ER

Prescription Icon
Prescription Required

Marketer

Vatican Life Sciences Pvt Ltd

Salt Composition

Gliclazide (80mg) + Metformin (500mg)

Overview V-Glyme-M 80 Tablet ER

Glyme-M 80 Extended-Release tablets are classified as antidiabetic medications. This dual-action formulation treats type 2 diabetes in adults by regulating blood glucose. Administer this medication with food, consistently at the same time daily for optimal effectiveness. Dosage is determined by your physician and may be adjusted based on your blood sugar response. Continued use is crucial, even with controlled glucose levels, as abrupt cessation can elevate blood sugar, potentially causing kidney damage, vision impairment, neuropathy, and limb loss. This medication forms part of a comprehensive diabetes management plan incorporating a balanced diet, regular exercise, and weight management as directed by your doctor. Lifestyle modifications are vital for diabetes control. Common adverse effects include hypoglycemia (low blood sugar), constipation, and nausea. Familiarize yourself with hypoglycemia symptoms (sweating, dizziness, headache, tremors) and appropriate countermeasures, such as readily available glucose sources (e.g., sugary snacks, fruit juice). Alcohol consumption can exacerbate hypoglycemia and should be avoided. Other possible side effects encompass altered taste, diarrhea, abdominal discomfort, headache, and upper respiratory infections. Weight gain may occur. This medication is contraindicated in patients with type 1 diabetes, diabetic ketoacidosis, or severe hepatic or renal impairment. Individuals with a history of heart disease should inform their physician before commencing treatment. Pregnant or lactating women should seek medical counsel prior to use. Regular blood glucose monitoring is essential, and your doctor may order blood tests to assess blood cell counts and liver function.

Primary Ingredients of V-Glyme-M 80 Tablet ER

No text provided. Please provide the text you wish to be rewritten.

Uses of V-Glyme-M 80 Tablet ER

Diabetes mellitus type 2

Major Benefits of V-Glyme-M 80 Tablet ER:

Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment duration. Ingest the entire tablet; avoid chewing, crushing, or fracturing it. Administer V-Glyme-M 80 Tablet ER with a meal.

Common Side effects of V-Glyme-M 80 Tablet ER:

  • Hypoglycemia (low blood glucose level)
  • Headache
  • Dizziness
  • Diarrhea
  • Upper respiratory tract infection
  • Nausea
  • Flatulence
  • Constipation

How to use V-Glyme-M 80 Tablet ER:

Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and duration. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. V-Glyme-M 80 Tablet ER should be administered with a meal.

How V-Glyme-M 80 Tablet ER works:

Gliclazide and metformin are combined in the extended-release tablet, V-Glyme-M 80.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Avoid alcohol consumption while taking V-Glyme-M 80 Tablet ER.

PregnancyPregnancyCONSULT YOUR DOCTOR

Extended-release V-Glyme-M 80 tablets pose a confirmed risk to a developing fetus and should not be taken during pregnancy. In exceptional, life-threatening circumstances, a physician might prescribe it if the potential benefits outweigh the known hazards. Physician consultation is essential.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

Extended-release V-Glyme-M 80 tablets are likely unsafe for breastfeeding mothers. Available evidence indicates potential transfer to breast milk, posing a risk to the infant.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.

KidneyKidneyCAUTION

Patients with kidney impairment should use V-Glyme-M 80 Tablet ER cautiously, potentially requiring dosage modification. Consult a physician for guidance. V-Glyme-M 80 Tablet ER is contraindicated in individuals with severe kidney disease. Regular monitoring of renal function is recommended during treatment.

LiverLiverCAUTION

Patients with liver impairment should use V-Glyme-M 80 Tablet ER cautiously, potentially requiring dosage modification. Physician consultation is advised. For those with mild to moderate liver disease, V-Glyme-M 80 Tablet ER should typically begin at a low dose; however, it's contraindicated in patients with severe hepatic dysfunction.

What if you forget to take V-Glyme-M 80 Tablet ER :

Should you forget to take a V-Glyme-M 80 Tablet ER, administer it immediately upon remembrance. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual medication routine. Avoid taking a double dose.

Facts to Know About V-Glyme-M 80 Tablet ER

LabelValue
Developing Habits No.
Treatment Category Diabetes Treatment

FAQs on V-Glyme-M 80 Tablet ER

V-Glyme-M 80 Tablet ER combines gliclazide and metformin to manage type 2 diabetes mellitus (DM) in adults. This medication improves blood sugar control when used with diet and exercise. Gliclazide stimulates insulin release from the pancreas, while metformin reduces liver glucose production and enhances insulin sensitivity. It's not suitable for type 1 DM.
V-Glyme-M 80 Tablet ER may cause common side effects such as hypoglycemia, altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory infection. Rare but serious side effects include lactic acidosis. Prolonged use may also result in vitamin B12 deficiency.
V-Glyme-M 80 Tablet ER can cause low blood sugar (hypoglycemia), manifesting as nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, anxiety, or shakiness. This risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other diabetes medications. Therefore, regular blood sugar monitoring is crucial. Carry glucose tablets, honey, or fruit juice for emergencies.
V-Glyme-M 80 Tablet ER can cause lactic acidosis, a serious medical emergency characterized by high blood lactic acid levels (also known as MALA, or Metformin-associated lactic acidosis). This rare side effect is more likely in patients with kidney disease, older adults, or those who consume excessive alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If you experience these, discontinue V-Glyme-M 80 Tablet ER and seek immediate medical attention.
Prolonged use of V-Glyme-M 80 Tablet ER can lead to vitamin B12 deficiency by interfering with its absorption. This deficiency, if left untreated, may result in anemia, nerve damage (manifested as tingling, numbness in extremities, weakness), urinary issues, cognitive changes, and balance problems (ataxia). To mitigate this risk, annual supplemental vitamin B12 is recommended by some researchers.
V-Glyme-M 80 Tablet ER is contraindicated in patients with allergies to its components or excipients, and in those with moderate to severe kidney disease or metabolic acidosis (including diabetic ketoacidosis).
Combining alcohol and V-Glyme-M 80 Tablet ER is unsafe. This combination may worsen low blood sugar and raise the risk of lactic acidosis.
V-Glyme-M 80 Tablet ER combines gliclazide and metformin to manage type 2 diabetes mellitus (DM) in adults. This medication improves blood sugar control when used with diet and exercise. Gliclazide stimulates insulin release from the pancreas, while metformin reduces liver glucose production and enhances insulin sensitivity. It's not suitable for type 1 DM.
V-Glyme-M 80 Tablet ER may cause common side effects such as hypoglycemia, altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory infection. Rare but serious side effects, including lactic acidosis, are also possible. Prolonged use may result in vitamin B12 deficiency.
V-Glyme-M 80 Tablet ER can cause low blood sugar (hypoglycemia), manifesting as nausea, headache, irritability, hunger, sweating, dizziness, rapid heart rate, anxiety, or shakiness. This risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other diabetes medications. Regular blood sugar monitoring is crucial. Carry glucose tablets, honey, or fruit juice to treat low blood sugar.
V-Glyme-M 80 Tablet ER can cause lactic acidosis, a serious medical emergency characterized by high blood lactic acid levels (also known as MALA, or Metformin-associated lactic acidosis). This rare side effect is more likely in patients with kidney disease, older adults, or those who consume excessive alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and slow heart rate. If you experience these, discontinue V-Glyme-M 80 Tablet ER and seek immediate medical attention.
Prolonged use of V-Glyme-M 80 Tablet ER can lead to vitamin B12 deficiency by interfering with its stomach absorption. This deficiency, if left untreated, may result in anemia, neurological issues such as tingling, numbness in extremities, weakness, urinary dysfunction, cognitive changes, and ataxia. To mitigate this risk, supplemental vitamin B12 at least annually is recommended by some researchers.
V-Glyme-M 80 Tablet ER is contraindicated in patients with allergies to its components or excipients, and in those with moderate to severe kidney disease or metabolic acidosis (including diabetic ketoacidosis).
Combining alcohol and V-Glyme-M 80 Tablet ER is unsafe. This combination risks dangerously low blood sugar (hypoglycemia) and increased lactic acidosis.
V-Glyme-M 80 Tablet ER
67
MRP 78
14% off